Abstract

Abstract Breast cancer is the most common cancer in North American women and is the second leading cause of cancer deaths in women today. Despite recent advances in treatment of breast cancer the development of chemo- and radio-resistance remains a major obstacle in treating advanced breast cancer. The aryl hydrocarbon receptor (AhR) is overexpressed and constitutively activated in several human breast carcinoma cell lines and the expression levels showed strong correlation with the degree of the tumor malignancy. In the current study, we evaluated the effect of reducing AhR expression on the chemo- and radio-sensitization of the MDA-MB231 human breast cancer cell line. We stably knocked down (KD) AhR expression in MDA-MB231 by using retroviral vectors expressing AhR-specific shRNA. Results show that reducing AhR expression enhanced radiation-induced apoptosis as shown by FITC-annexin V assay as well as significantly reducing cell clonogenic survival of MDA-MB231 cell line. In addition, knockdown of AhR alone has significantly impacted expression of genes regulating apoptotic pathways in these cells; increasing the expression of a number of pro-apoptotic genes while anti-apoptotic genes were down-regulated. Furthermore, the AhR-KD MDA-MB231 cells were sensitized to paclitaxol treatment; seen as an increase in the dose-dependent cytotoxicity compared to control cells. Our results suggest that reduction of AhR expression increases the chemo- and radio-sensitivity of MDA-MB231 breast cancer cell line. Therefore, AhR could be a novel target for enhancing efficacy of chemo and radiotherapy of breast cancer. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 1455. doi:1538-7445.AM2012-1455

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.